Neos Therapeutics (NEOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 24,777 | 31,969 | 43,398 | 57,362 | 43,661 |
| Marketable Securities | 12,444 | 18,448 | 23,089 | 21,262 | 10,571 |
| Receivables | 19,642 | 13,671 | 8,619 | 5,669 | 11,852 |
| Inventories | 13,399 | 11,732 | 9,992 | 6,080 | 5,592 |
| Other current assets | 2,841 | 3,575 | 2,830 | 2,688 | 2,979 |
| TOTAL | $73,103 | $79,395 | $87,928 | $93,061 | $74,655 |
| Non-Current Assets | |||||
| PPE Net | 8,173 | 8,203 | 8,323 | 8,223 | 6,953 |
| Intangibles | 15,931 | 16,348 | 16,739 | 16,879 | 15,189 |
| Other Non-Current Assets | 149 | 162 | 192 | 185 | 2,219 |
| TOTAL | $24,253 | $24,713 | $25,254 | $25,287 | $24,361 |
| Total Assets | $97,356 | $104,108 | $113,182 | $118,348 | $99,016 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 948 | 896 | 6,949 | 7,022 | 6,996 |
| Accounts payable and accrued liabilities | 10,662 | 11,460 | 10,706 | 8,290 | 6,985 |
| Accrued Expenses | 28,580 | 20,944 | 9,385 | 8,414 | 7,065 |
| TOTAL | $40,190 | $33,300 | $36,367 | $30,619 | $25,979 |
| Non-Current Liabilities | |||||
| Long Term Debt | 58,973 | 58,938 | 58,970 | 59,001 | 59,010 |
| Deferred Revenues | N/A | N/A | 9,327 | 6,893 | 4,933 |
| Other Non-Current Liabilities | 1,653 | 1,840 | 2,039 | 2,284 | 266 |
| TOTAL | $61,685 | $61,861 | $62,115 | $62,413 | $60,427 |
| Total Liabilities | $101,875 | $95,161 | $98,482 | $93,032 | $86,406 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 28,997 | 28,997 | 28,997 | 28,081 | 22,561 |
| Common Shares | 29 | 29 | 28 | 27 | 23 |
| Retained earnings | -279,744 | -265,308 | -252,141 | -235,882 | -217,208 |
| Other shareholders' equity | -355 | -358 | -233 | -238 | -235 |
| TOTAL | $-4,519 | $8,947 | $14,700 | $25,316 | $12,610 |
| Total Liabilities And Equity | $97,356 | $104,108 | $113,182 | $118,348 | $99,016 |